Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Wenguang Chang & Peifeng Li. (2023) Bone marrow mesenchymal stromal cell-derived small extracellular vesicles: A novel therapeutic agent in ischemic heart diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Liang ZhuSheng WangJunSheng QuZongguang HuiChengxia KanNingning HouXiaodong Sun. (2022) The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus. Cellular Reprogramming 24:6, pages 329-342.
Crossref
Crossref
Yuexin Zhu, Manyu Luo, Xue Bai, Yan Lou, Ping Nie, Shan Jiang, Jicui Li, Bing Li & Ping Luo. (2022) Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence. Molecular and Cellular Biochemistry 477:8, pages 2073-2092.
Crossref
Crossref
Shady G. El-Sawah, Hanan M. Rashwan, Fayez Althobaiti, Adil Aldhahrani, Eman Fayad, El-Shaimaa Shabana, Ehab I. El-Hallous & Rehab M. Amen. (2022) AD-MSCs and BM-MSCs Ameliorating Effects on The Metabolic and Hepato-renal Abnormalities in Type 1 Diabetic Rats. Saudi Journal of Biological Sciences 29:2, pages 1053-1060.
Crossref
Crossref
MDolores Carmona, Luis-Miguel Paco-Meza, Rosa Ortega, Sagrario Cañadillas, Javier Caballero-Villarraso, Alfonso Blanco & Concha Herrera. (2022) Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy. Pathology - Research and Practice 230, pages 153756.
Crossref
Crossref
SHADY G. EL-SAWAH, FAYEZ ALTHOBAITI, HANAN M. RASHWAN, ADIL ALDHAHRANI, MARWA A. ABDEL-DAYEM, EMAN FAYAD, REHAB M. AMEN, EL SHAIMAA SHABANA & EHAB I. EL-HALLOUS. (2022) Anti-inflammatory and antioxidant potential capacities of AD-MSCs and BM-MSCs in suppressing pancreatic β-cells auto-immunity and apoptosis in rats with T1DM induced model. BIOCELL 46:3, pages 745-757.
Crossref
Crossref
Ning Xu, Jie Liu & Xiangling Li. (2022) Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD). Endocrine Journal 69:10, pages 1159-1172.
Crossref
Crossref
Ping Nie, Xue Bai, Yan Lou, Yuexin Zhu, Shan Jiang, Lina Zhang, Na Tian, Ping Luo & Bing Li. (2021) Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Jinyi Xu & Chengguo Zuo. (2021) The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Lan Li, Dongqi Cheng, Xingxing An, Guangneng Liao, Ling Zhong, Jingping Liu, Younan Chen, Yujia Yuan & Yanrong Lu. (2021) Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats. International Immunopharmacology 99, pages 108000.
Crossref
Crossref
LaTonya J. Hickson, Tala Abedalqader, Gift Ben-Bernard, Jayla M. Mondy, Xiaohui Bian, Sabena M. Conley, Xiangyang Zhu, Sandra M. Herrmann, Aleksandra Kukla, Elizabeth C. Lorenz, Seo Rin Kim, Bjorg Thorsteinsdottir, Lilach O. Lerman & M. Hassan Murad. (2021) A Systematic Review and Meta-Analysis of Cell-Based Interventions in Experimental Diabetic Kidney Disease. Stem Cells Translational Medicine 10:9, pages 1304-1319.
Crossref
Crossref
Heba A. Habib, Gehan H. Heeba & Mohamed M.A. Khalifa. (2021) Comparative effects of incretin-based therapy on early-onset diabetic nephropathy in rats: Role of TNF-α, TGF-β and c-caspase-3. Life Sciences 278, pages 119624.
Crossref
Crossref
Yinghui Wang, Jiaxi Liu, Qingqing Zhang, Weiwei Wang, Qingzhen Liu, Shanshan Liu, Yan Song, Xueling Wang, Yaping Zhang, Shan Li, Xue Yang, Shasha Lv & Gang Liu. (2021) Human umbilical cord mesenchymal stem cells attenuate podocyte injury under high glucose via TLR2 and TLR4 signaling. Diabetes Research and Clinical Practice 173, pages 108702.
Crossref
Crossref
Heba A. Habib, Gehan H. Heeba & Mohamed M.A. Khalifa. (2021) Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats. European Journal of Pharmacology 892, pages 173721.
Crossref
Crossref
Wenshan Lin, Hong-Yan Li, Qian Yang, Guangyong Chen, Shujun Lin, Chunling Liao & Tianbiao Zhou. (2021) Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
SHADY G. EL-SAWAH, FAYEZ ALTHOBAITI, ADIL ALDHAHRANI, EMAN FAYAD, MARWA A. ABDEL-DAYEM, REHAB M. AMEN, EL SHAIMAA SHABANA, EHAB I. EL-HALLOUS & HANAN M. RASHWAN. (2021) Investigation of the antioxidant defensive role of both AD-MSCs and BM-MSCs in modulating the alteration in the oxidative stress status in various STZ-diabetic rats’ tissues. BIOCELL 45:6, pages 1561-1568.
Crossref
Crossref
Christian Sávio-Silva, Stephany Beyerstedt, Poliana E. Soinski-Sousa, Expedito B. Casaro, Maria Theresa A. Balby-Rocha, Antônio Simplício-Filho, Jamille Alves-Silva & Érika B. Rangel. (2020) Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells. Stem Cells International 2020, pages 1-28.
Crossref
Crossref
Mingjuan He, Yixiang Li, Li Wang, Bei Guo, Wen Mei, Biao Zhu, Jiajia Zhang, Yan Ding, Biying Meng, Liming Zhang, Lin Xiang, Jing Dong, Min Liu, Lingwei Xiang & Guangda Xiang. (2020) MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease. Diabetologia 63:9, pages 1916-1931.
Crossref
Crossref
Binbin Pan & Guoping Fan. (2020) Stem cell-based treatment of kidney diseases. Experimental Biology and Medicine 245:10, pages 902-910.
Crossref
Crossref
Fateme Guitynavard, Seyed Mohammad Kazem Aghamir & Diana Taheri. 2020. Stem Cells in Urology. Stem Cells in Urology
101
117
.
Safaa Y. Sayed, Shaymaa I. Salem, Ahmed N. Abdallah, Ghada M. Khalil & Faten F. Mohammed. (2019) Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats. Comparative Clinical Pathology 28:5, pages 1515-1526.
Crossref
Crossref
Abduzhappar Gaipov, Zhannat Taubaldiyeva, Manarbek Askarov, Zaiyrkhan Turebekov, Larisa Kozina, Askhat Myngbay, Olga Ulyanova & Saltanat Tuganbekova. (2018) Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy. Journal of Nephrology 32:1, pages 65-73.
Crossref
Crossref
Maria V. Irazabal, LaTonya J. Hickson & Alfonso Eirin. 2019. A Roadmap to Non-Hematopoietic Stem Cell-based Therapeutics. A Roadmap to Non-Hematopoietic Stem Cell-based Therapeutics
275
296
.
Md Shaifur Rahman, Lucas-Sebastian Spitzhorn, Wasco Wruck, Carsten Hagenbeck, Percy Balan, Nina Graffmann, Martina Bohndorf, Audrey Ncube, Pascale V. Guillot, Tanja Fehm & James Adjaye. (2018) The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
Bou-Yue Peng, Navneet Kumar Dubey, Viraj Krishna Mishra, Feng-Chou Tsai, Rajni Dubey, Win-Ping Deng & Hong-Jian Wei. (2018) Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications. Journal of Diabetes Research 2018, pages 1-16.
Crossref
Crossref
Adriana Torres Crigna, Cristina Daniele, Carolina Gamez, Sara Medina Balbuena, Diego O. Pastene, Daniela Nardozi, Cinzia Brenna, Benito Yard, Norbert Gretz & Karen Bieback. (2018) Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. Frontiers in Medicine 5.
Crossref
Crossref
Rui Xue, Dingkun Gui, Liyang Zheng, Ruonan Zhai, Feng Wang & Niansong Wang. (2017) Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. Journal of Diabetes Research 2017, pages 1-7.
Crossref
Crossref